Indication & Dosage | Oral Tapeworm infections Adult: 1 g every 15 minutes for 4 doses. For cestodiasis caused by Hymenolepis nana: 45 mg/kg daily, given as a single dose for 5-7 days. Child: For infections caused by D. latum, D. caninum, T. saginata or T. solium: 11 mg/kg every 15 min for 4 doses. For infections caused by H. nana: 45 mg/kg/day, given as a single dose for 5-7 days. Oral Cryptosporidiosis Adult: In AIDS patients: 1.5-2.25 g/day in 3-6 divided doses for 10-14 days (courses up to 4-8 wk may be needed). Oral Giardiasis Adult: 25-35 mg/kg/day in 3 divided doses for 7 days. Child: 25-35 mg/kg/day tid for 7 days. Oral Dientamoeba fragilis infections Adult: 25-35 mg/kg/day in 3 divided doses for 7 days. Child: 25-35 mg/kg/day tid for 7 days. Oral Hepatic encephalopathy Adult: Adjunct in the management of hepatic coma: 4 g daily in divided doses for 5-6 days. Oral Amoebiasis Adult: Caused by Entamoeba histolytica: 25-35 mg/kg/day in 3 divided doses for 5-10 days. Child: 25-35 mg/kg/day tid for 5-10 days. Intramuscular Visceral leishmaniasis Adult: 11-20 mg/kg/day for 10-21 days. Topical/Cutaneous Cutaneous leishmaniasis Adult: Paromomycin sulfate 15% and methylbenzethonium chloride 12% in white petrolatum: Apply bid for 10-20 days. |
||||||||||||
Administration | Should be taken with food. (Take during meals.) | ||||||||||||
Overdosage | Nausea, vomiting, diarrhoea. Care is supportive and symptomatic. | ||||||||||||
Contraindications | Intestinal obstruction. | ||||||||||||
Special Precautions | Renal impairment; ulcerative lesions of the bowel to avoid renal toxicity through inadvertent absorption. Prolonged use may result in fungal or bacterial superinfection. Pregnancy. Do not use alone in the treatment of extraintestinal amoebiasis. | ||||||||||||
Adverse Drug Reactions | Diarrhoea, abdominal cramps, nausea, vomiting, heartburn. Rarely: Headache, vertigo, exanthema, rash, pruritus, steatorrhoea, secondary enterocolitis, eosinophilia, ototoxicity. | ||||||||||||
Drug Interactions | Decreased effect of digoxin, vitamin A, and methotrexate; increased effect of oral anticoagulants, neuromuscular blockers, and polypeptide antibiotics. | ||||||||||||
Food Interaction | Malabsorption of xylose, sucrose, and fats. | ||||||||||||
Pregnancy Category (US FDA) |
|
||||||||||||
Storage | Intramuscular: Store at 15-30°C. Protect from moisture. Oral: Store at 15-30°C. Protect from moisture. Topical/Cutaneous: Store at 15-30°C. Protect from moisture. | ||||||||||||
Mechanism of Action | Paromomycin
is an aminoglycoside antibiotic with antibacterial and antiprotozoal
activity. It is a luminal or contact amoebicide since it acts primarily
in the intestinal lumen. It is direct-acting, and is effective either in
the presence or absence of bacteria. Paromomycin is bactericidal and
inhibits protein synthesis in susceptible bacteria at the 30S ribosomal
unit. Absorption: Poorly from the GI tract. Rapidly following IM inj; peak plasma concentrations achieved within 1 hr. Excretion: Via faeces (100% as unchanged drug); any absorbed drug via urine.http://www.mims.com/Philippines/drug/info/paromomycin/?type=full&mtype=generic#Dosage |
is a class of pharmaceuticals used in treatment of protozoan infection. Protozoans have little in common with each other (for example, Entamoeba histolytica is less closely related to Naegleria fowleri than it is to Homo sapiens) and so agents effective against one pathogen may not be effective against another. However, metronidazole is selective for anaerobic organisms, and so it is effective against many (though not all) of these pathogens. http://en.wikipedia.org/wiki/Antiprotozoal_agent
Linggo, Enero 29, 2012
paromomycin
Mag-subscribe sa:
I-post ang Mga Komento (Atom)
Walang komento:
Mag-post ng isang Komento